Here are six highlights:
1. The demand for more neurostimulation techniques with efficient algorithms will spur market growth.
2. An increase in cerebral stroke and other neurological disorders will also contribute to market growth.
3. In 2014, neurostimulation devices accounted for more than 50 percent of global market revenue.
4. North America led the market in 2014, with revenues of more than $2.4 billion. Good healthcare infrastructure, favorable government policies, cancer research and neurological research and development investment will continue to drive the market in this area.
5. Asia-Pacific is expected to see a compound annual growth rate of more than 8 percent between 2015 and 2022. Increasing research and development investment and growing medical expenditures in India and China will support market growth.
6. Key market players include Johnson and Johnson, B.Braun Melsungen, Boston Scientific, St. Jude Medical, Covidien, Medtronic, Magstim, W.L. Gore & Associates, Integra LifeSciences and Stryker.
More articles on devices:
How did 5 orthopedic device giants fare in the most recent fiscal period? 45 notes on Stryker, Medtronic & more
Eden Spine’s SPHYNX plating system receives CE Mark: 5 points
VirtaMed unveils hip arthroscopy simulator: 4 things to know
